Tactile Systems Technology logo
Tactile Systems Technology TCMD
$ 28.92 0.38%

Annual report 2025
added 02-17-2026

report update icon

Tactile Systems Technology Financial Statements 2011-2026 | TCMD

Annual Financial Statements Tactile Systems Technology

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

640 M 428 M 322 M 270 M 375 M 869 M 1.08 B 1.21 B 561 M 251 M - - - - -

Shares

22.9 M 23.9 M 22.9 M 20.1 M 19.7 M 19.3 M 18.9 M 18.3 M 17.4 M 16.8 M - - - - -

Historical Prices

28 17.9 14.1 13.5 19 44.9 67.5 45.5 29 16.4 - - - - -

Net Income

19.1 M 17 M 28.5 M -17.9 M -11.8 M -620 K 11 M 6.62 M 5.86 M 2.88 M 1.39 M 2.07 M 3.16 M - -

Revenue

330 M 293 M 274 M 247 M 208 M 187 M 189 M 144 M 109 M 84.5 M 62.9 M 47.7 M 37.2 M - -

Cost of Revenue

79.4 M 76.3 M 79.3 M 70.8 M 59.8 M 54.3 M 55.3 M 41.5 M 29 M 22.9 M 16.9 M 12.7 M - - -

Gross Profit

250 M 217 M 195 M 176 M 148 M 133 M 134 M 102 M 80.3 M 61.6 M 46 M 35 M 27.4 M - -

Operating Income

29.3 M 22.2 M 18 M -12.8 M -1.76 M -3.63 M 10.5 M 2.99 M 3.9 M 4.27 M 3.45 M 3.8 M - - -

EBITDA

35.9 M 29 M 24.6 M -6.49 M 1.92 M -834 K 14 M 6.62 M 5.75 M 5.07 M 4.28 M 4.5 M 2.96 M - -

Operating Expenses

221 M 195 M 177 M 189 M 150 M 136 M 124 M 99.3 M 76.4 M 57.3 M 42.5 M 31.2 M 25 M - -

General and Administrative Expenses

88.7 M 71.1 M 62.1 M 60.8 M 56.8 M 51.3 M 39.6 M 33.6 M 26.9 M 19.1 M 13.7 M 10.2 M 8.28 M - -

All numbers in USD currency

Quarterly Income Statement Tactile Systems Technology

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

22.3 M 23.1 M 23.7 M 23.9 M 24 M 23.9 M 23.7 M 23.6 M 23.5 M 23.4 M 21.3 M 20.3 M 20.1 M 20 M 19.9 M 19.9 M 19.8 M 19.7 M 19.5 M 19.5 M 19.4 M 19.3 M 19.2 M 19.2 M 19 M 18.9 M 18.7 M 18.6 M 18.3 M 18.2 M 18 M 17.8 M 17.6 M 17.2 M 16.9 M 16.8 M 12.3 M 3.41 M 3.29 M 3.22 M 3.15 M 2.81 M - - - - - - - - - - - - - - - - -

Net Income

8.21 M 3.22 M -2.97 M - 5.16 M 4.3 M -2.21 M - 22.3 M -100 K -1.89 M - -2.28 M -4.64 M -15.6 M - -4.32 M 1.3 M -2.27 M 12.1 M 2.42 M -13.8 M -1.31 M 4.28 M 2.43 M 2.78 M 1.47 M 2.36 M 1.75 M 2.57 M -50 K 2.23 M 1.34 M 3.79 M -1.5 M 2.38 M 492 K 988 K -980 K 289 K 876 K 138 K -1.34 M - - - - - - - - - - - - - - - -

Revenue

85.8 M 78.9 M 61.3 M - 73.1 M 73.2 M 61.1 M - 69.6 M 68.3 M 58.8 M - 65.3 M 59.6 M 48 M - 52.5 M 51.1 M 42.8 M 59.2 M 49.1 M 35.1 M 43.7 M 57.1 M 49.6 M 45.2 M 37.6 M 46.4 M 36.3 M 34.1 M 26.8 M 34.9 M 28.3 M 26.3 M 19.8 M 28.5 M 22.6 M 19.7 M 13.7 M 21.2 M 16.8 M 14.8 M 10.1 M - - - - - - - - - - - - - - - -

Cost of Revenue

20.8 M 20.1 M 15.9 M - 18.3 M 19.1 M 17.7 M - 20.2 M 20 M 17.4 M - 18.5 M 16.4 M 14.1 M - 15.5 M 14.9 M 12.5 M - 14.1 M 10.2 M 12.6 M - 14.2 M 13.7 M 11.4 M - 10.1 M 9.61 M 7.31 M - 7.53 M 7.03 M 5.62 M - 6.28 M 5.32 M 3.81 M - 4.47 M 4.4 M - - - - - - - - - - - - - - - - -

Gross Profit

65 M 58.8 M 45.3 M - 54.8 M 54.1 M 43.4 M - 49.4 M 48.3 M 41.5 M - 46.8 M 43.2 M 33.9 M - 37 M 36.2 M 30.2 M 41.9 M 35 M 24.9 M 31.1 M 41.1 M 35.4 M 31.5 M 26.3 M 32 M 26.2 M 24.5 M 19.5 M 26.1 M 20.8 M 19.2 M 14.2 M 21 M 16.4 M 14.4 M 9.89 M 16.1 M 12.4 M 10.4 M 7.15 M - - - - - - - - - - - - - - - -

Operating Income

11 M 4.08 M -4.54 M - 6.78 M 5.85 M -2.96 M - 7.99 M 2.06 M -3.81 M - -1.62 M -4.09 M -14.9 M - -1.37 M -76 K -4.08 M 6.99 M 1.79 M -7.96 M -4.45 M 6.05 M 3.2 M 3.05 M -1.8 M 2.14 M 1.37 M 1.31 M -1.83 M 4.93 M 1.26 M 730 K -2.93 M 3.29 M 974 K 1.79 M -1.79 M 3.24 M 1.46 M 228 K -1.48 M - - - - - - - - - - - - - - - -

EBITDA

11.9 M 4.98 M -2.82 M - 7.68 M 6.85 M -1.33 M - 8.89 M 3.06 M -2.18 M - -620 K -3.09 M -13.4 M - 783 K 24 K -3.43 M 6.99 M 3.9 M -6.51 M -3.72 M 6.05 M 6.01 M 5.03 M -738 K 2.14 M 3.84 M 3 M -1.36 M 4.93 M 2.33 M 1.39 M -2.63 M 3.29 M 1.65 M 2.23 M -1.58 M 3.24 M 2.08 M 639 K -1.48 M - - - - - - - - - - - - - - - -

Operating Expenses

54 M 54.7 M 49.9 M - 48 M 48.3 M 46.4 M - 41.4 M 46.2 M 45.3 M - 48.4 M 47.3 M 48.8 M - 38.3 M 36.3 M 34.3 M - 33.2 M 32.9 M 35.5 M - 32.2 M 28.5 M 28.1 M - 24.8 M 23.2 M 21.4 M - 19.6 M 18.5 M 17.2 M - 15.4 M 12.6 M 11.7 M - 10.9 M 10.1 M - - - - - - - - - - - - - - - - -

General and Administrative Expenses

21.4 M 22 M 20 M - 18.1 M 16.8 M 16.3 M - 16.4 M 15 M 15.4 M - 16.3 M 14.9 M 16.2 M - 14.5 M 14.1 M 14.2 M - 12.5 M 14.4 M 10.9 M - 9.97 M 8.81 M 9.39 M - 7.96 M 7.47 M 7.37 M - 7.55 M 6.39 M 5.87 M - 5.12 M 3.97 M 3.41 M - 3.6 M 3.2 M - - - - - - - - - - - - - - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Tactile Systems Technology TCMD
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Tactile Systems Technology plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Bruker Corporation Bruker Corporation
BRKR
$ 37.3 1.69 % $ 5.56 K usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
$ 71.94 0.83 % $ 106 B usaUSA
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
$ 8.89 2.3 % $ 638 M israelIsrael
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
$ 11.53 15.25 % $ 312 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
CONMED Corporation CONMED Corporation
CNMD
$ 39.34 -1.4 % $ 1.22 B usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.8 0.13 % $ 43.5 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 12.8 4.66 % $ 1.92 B usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.18 1.1 % $ 329 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 4.2 1.69 % $ 157 M franceFrance
Electromed Electromed
ELMD
$ 24.44 2.35 % $ 207 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
$ 68.68 -2.46 % $ 2.03 B costa-ricaCosta-rica
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 83.95 2.83 % $ 49.1 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
$ 18.49 - $ 121 M usaUSA
Globus Medical Globus Medical
GMED
$ 87.8 0.8 % $ 11.9 B usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.31 5.25 % $ 1.4 M usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.56 -1.75 % $ 736 M usaUSA
Butterfly Network Butterfly Network
BFLY
$ 3.81 4.25 % $ 807 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Inogen Inogen
INGN
$ 6.38 -1.47 % $ 170 M usaUSA
InMode Ltd. InMode Ltd.
INMD
$ 13.26 0.23 % $ 857 M israelIsrael
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.33 7.12 % $ 21.5 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
IRadimed Corporation IRadimed Corporation
IRMD
$ 100.0 1.3 % $ 1.27 B usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
$ 85.53 1.79 % $ 2.97 B usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 18.72 3.71 % $ 439 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 1.75 2.94 % $ 2.73 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 62.23 -2.52 % $ 3.39 B britainBritain
LENSAR LENSAR
LNSR
$ 11.91 0.93 % $ 137 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.83 -9.53 % $ 71.6 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA